S01316 Summary:

BILL NOS01316A
 
SAME ASNo Same As
 
SPONSORLITTLE
 
COSPNSRKENNEDY, MARCHIONE, ORTT
 
MLTSPNSR
 
Amd §213, Ins L
 
Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.
Go to top    

S01316 Actions:

BILL NOS01316A
 
01/09/2017REFERRED TO INSURANCE
01/03/2018REFERRED TO INSURANCE
01/24/2018AMEND AND RECOMMIT TO INSURANCE
01/24/2018PRINT NUMBER 1316A
Go to top

S01316 Committee Votes:

Go to top

S01316 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S01316 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         1316--A
 
                               2017-2018 Regular Sessions
 
                    IN SENATE
 
                                     January 9, 2017
                                       ___________
 
        Introduced  by  Sens. LITTLE, KENNEDY, MARCHIONE, ORTT -- read twice and
          ordered printed, and when printed to be committed to the Committee  on
          Insurance  --  recommitted to the Committee on Insurance in accordance
          with Senate Rule 6, sec. 8  --  committee  discharged,  bill  amended,
          ordered reprinted as amended and recommitted to said committee

        AN ACT to amend the insurance law, in relation to directing the New York
          state health care quality and cost containment commission to study and
          report  upon  the  impact  of  requiring that certain health insurance
          plans provide coverage for treatment of mitochondrial disease
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. Section 213 of the insurance law is amended by adding a new
     2  subsection (e) to read as follows:
     3    (e)  The  commission shall cause a study to be performed on the impact
     4  of requiring certain health insurance  plans  to  provide  coverage  for
     5  treatment  of mitochondrial disease. Such study shall include an assess-
     6  ment of the impact of such a requirement on costs to providers, the cost
     7  of insurance premiums, and the fiscal impact to the state.  The  commis-
     8  sion  shall submit a report of the findings, conclusions and recommenda-
     9  tion of such study, on or before November thirtieth, two thousand  nine-
    10  teen,  to  the  governor,  the  temporary  president  of the senate, the
    11  speaker of the assembly, the chairs of the senate and assembly insurance
    12  committees, and the chairs of the senate and assembly health committees.
    13    § 2. This act shall take effect immediately.
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00580-02-8
Go to top